Fundraising FoxLuminoma
Auckland, NZ · 3 known investors
Find your way into Luminoma
Sign up to see every warm intro you have to Luminoma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Luminoma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Luminoma is developing the LumAssure, a portable diagnostic-aid that uses Raman spectroscopy to non-invasively assess whether a skin lesion is likely malignant or benign within seconds. The device is intended to help clinicians make more objective skin cancer biopsy decisions and reduce unnecessary biopsies.
Founders & leadership
CS
MN
Michel NieuwoudtChief Scientific OfficerMichel Nieuwoudt is Chief Scientific Officer at Luminoma, where he leads development of portable spectroscopic diagnostic systems. He has expertise in Raman and FTIR spectroscopy, chemometrics, and materials science, with a focus on applying vibrational spectroscopy methods to clinical applications including skin disease monitoring.
Investors · 3
Frequently asked questions
- What does Luminoma do?
- Luminoma is developing the LumAssure, a portable diagnostic-aid that uses Raman spectroscopy to non-invasively assess whether a skin lesion is likely malignant or benign within seconds. The device is intended to help clinicians make more objective skin cancer biopsy decisions and reduce unnecessary biopsies.
- Who founded Luminoma?
- Luminoma was founded by Cather Simpson.
- Who are Luminoma's investors?
- Luminoma's investors include Angel HQ, Bridgewest Ventures, Pacific Channel.
- Where is Luminoma headquartered?
- Luminoma is headquartered in Auckland, NZ.